Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F

BACKGROUND: A somatic activating mutation (V617F) in the JAK2 tyrosine kinase was recently discovered in the majority of patients with polycythemia vera (PV), and some with essential thrombocythemia (ET) and chronic idiopathic myelofibrosis. However, the role of mutant JAK2 in disease pathogenesis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaleskas, Virginia M., Krause, Daniela S., Lazarides, Katherine, Patel, Nihal, Hu, Yiguo, Li, Shaoguang, Van Etten, Richard A.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762384/
https://www.ncbi.nlm.nih.gov/pubmed/17183644
http://dx.doi.org/10.1371/journal.pone.0000018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762384/
https://www.ncbi.nlm.nih.gov/pubmed/17183644
http://dx.doi.org/10.1371/journal.pone.0000018

Ejemplares similares